EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor-Intrinsic PD-L1 Promotes Breast Cancer Proliferation Through Livin and Galectin-1-Mediated Regulation of SKP2 Expression

Marwa Elfoly, Ayodele Alaiya iD, Amal A Al-Hazzani, Monther Al-Alwan iD, Hazem Ghebeh iD

International Journal of Molecular Sciences · 17.03.2026 · 27 (6) · 2741

DOI: 10.3390/ijms27062741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.03.2026. Verfasst von Marwa Elfoly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Innovation and Research, King Faisal Specialist Hospital & Research Centre, MBC 03, P.O. Box 3354, Riyadh 11211, Saudi Arabia. Hauptthemen laut MEDLINE: S-Phase Kinase-Associated Proteins, Breast Neoplasms, Adaptor Proteins, Signal Transducing, B7-H1 Antigen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Faisal Specialist Hospital & Research Centre, King Faisal Specialist Hospital & Research Centre project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmed Death-Ligand 1 (PD-L1) promotes tumor progression through several mechanisms, including its intrinsic effect on breast cancer cell proliferation via the S-Phase Kinase-Associated Protein 2 (SKP2)–p21Cip1/p27Kip1 (SKP2-p21/p27) axis. However, the specific regulatory signaling through which PD-L1 influences the SKP2–p21/p27 axis to drive cell proliferation remains unclear. To investigate how PD-L1 mediates SKP2-dependent proliferation, proteomic analyses, gene-expression manipulation via knockdown or overexpression, Western blotting, quantitative immunofluorescence, colony-forming assays, real-time cell analysis, and Xenograft-derived cells were used. Proteomic data analysis identified several PD-L1 downstream targets as potential candidate regulators of the SKP2–p21/p27 axis and activators of the PI3K/AKT pathway. Candidate screening by gene knockdown, followed by analyses of SKP2, p21, and p27 protein expression, revealed Livin and Galectin-1 as upstream regulators of the SKP2–p21/p27 axis. Moreover, Western blotting and quantitative immunofluorescence in three breast cancer cell lines confirmed that PD-L1 is an upstream regulator of Livin, Galectin-1, and SKP2 protein expression. Mechanistically, Livin and Galectin-1 enhanced AKT phosphorylation (Ser473) to sustain PI3K/AKT pathway activation in a positive feedback loop to upregulate SKP2 expression. Functional assays, including colony-forming assays and real-time cell analyzer, demonstrated that Livin and Galectin-1 are critical for PD-L1-mediated, SKP2-dependent proliferation. These findings were corroborated in vivo using xenograft-derived cells. Overall, these findings delineate a tumor-intrinsic signaling axis in which PD-L1 upregulates Livin and Galectin-1 to sustain PI3K/AKT activity and drive SKP2-dependent cell proliferation. Targeting Livin and/or Galectin-1 may provide a rational strategy to disrupt PD-L1-associated proliferative signaling and improve combinatorial therapeutic approaches in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

S-Phase Kinase-Associated ProteinsBreast NeoplasmsAdaptor Proteins, Signal TransducingB7-H1 AntigenGalectin 1Inhibitor of Apoptosis ProteinsNeoplasm ProteinsHumansFemaleCell ProliferationAnimalsCell Line, TumorGene Expression Regulation, NeoplasticMiceSignal TransductionCyclin-Dependent Kinase Inhibitor p27Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktCyclin-Dependent Kinase Inhibitor p21

Stichwörter der Autor:innen

BIRC7Galactin-1LGALS1LivinPD-L1SKP2proliferation

Substanzen

S-Phase Kinase-Associated ProteinsAdaptor Proteins, Signal TransducingSKP2 protein, humanB7-H1 AntigenGalectin 1Inhibitor of Apoptosis ProteinsNeoplasm ProteinsBIRC7 protein, humanCD274 protein, humanCyclin-Dependent Kinase Inhibitor p27

Autor:innen und Institutionen

  • Innovation and Research, King Faisal Specialist Hospital & Research Centre, MBC 03, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
  • Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.
  • College of Medicine, Al-Faisal University, P.O. Box 50927, Riyadh 11533, Saudi Arabia.

ORCID-Profile: Ayodele Alaiya, Monther Al-Alwan, Hazem Ghebeh

Förderung

  • King Faisal Specialist Hospital & Research Centre
  • King Faisal Specialist Hospital & Research Centre project

Zitieren

APA

Elfoly, M., Alaiya, A., Al-Hazzani, A. A., Al-Alwan, M., & Ghebeh, H. (2026). Tumor-Intrinsic PD-L1 Promotes Breast Cancer Proliferation Through Livin and Galectin-1-Mediated Regulation of SKP2 Expression. International Journal of Molecular Sciences, 27(6), 2741. https://doi.org/10.3390/ijms27062741

Vancouver

Elfoly M, Alaiya A, Al-Hazzani AA, Al-Alwan M, Ghebeh H. Tumor-Intrinsic PD-L1 Promotes Breast Cancer Proliferation Through Livin and Galectin-1-Mediated Regulation of SKP2 Expression. International Journal of Molecular Sciences. 2026;27(6):2741. doi:10.3390/ijms27062741

BibTeX
@article{Elfoly2026,
  author = {Elfoly, Marwa and Alaiya, Ayodele and Al-Hazzani, Amal A and Al-Alwan, Monther and Ghebeh, Hazem},
  title = {Tumor-Intrinsic PD-L1 Promotes Breast Cancer Proliferation Through Livin and Galectin-1-Mediated Regulation of SKP2 Expression},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2741},
  doi = {10.3390/ijms27062741}
}
Kostenlos starten →